Related references
Note: Only part of the references are listed.Rhein Suppresses Lung Inflammatory Injury Induced by Human Respiratory Syncytial Virus Through Inhibiting NLRP3 Inflammasome Activation via NF-κB Pathway in Mice
Cunsi Shen et al.
FRONTIERS IN PHARMACOLOGY (2020)
IgA nephropathy: A brief review
Jared R. Hassler
SEMINARS IN DIAGNOSTIC PATHOLOGY (2020)
Renal protection of rhein against 5/6 nephrectomied-induced chronic kidney disease: role of SIRT3-FOXO3 alpha signalling pathway
Xiaoxiao Wu et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2020)
Rhein attenuates renal inflammatory injury of uric acid nephropathy via lincRNA-Cox2/miR-150-5p/STAT1 axis
Jiacai Hu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Functional Metabolomics Analysis Elucidating the Metabolic Biomarker and Key Pathway Change Associated With the Chronic Glomerulonephritis and Revealing Action Mechanism of Rhein
Wei Yu et al.
FRONTIERS IN PHARMACOLOGY (2020)
Clinical and histological features and therapeutic strategies for IgA nephropathy
Takahito Moriyama
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2019)
A patent herbal drug Yi-Shen-Hua-Shi granule ameliorates C-BSA-induced chronic glomerulonephritis and inhabits TGFβ signaling in rats
Jing Zhao et al.
JOURNAL OF ETHNOPHARMACOLOGY (2019)
Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children
Monia Guidi et al.
MALARIA JOURNAL (2019)
The role of complement in IgA nephropathy
Agustin Tortajada et al.
MOLECULAR IMMUNOLOGY (2019)
A Significant Association Between Rhein and Diabetic Nephropathy in Animals: A Systematic Review and Meta-Analysis
Heng-Chang Hu et al.
FRONTIERS IN PHARMACOLOGY (2019)
Kidney-targeted rhein-loaded liponanoparticles for diabetic nephropathy therapy via size control and enhancement of renal cellular uptake
Guowei Wang et al.
THERANOSTICS (2019)
MiR-145-5p inhibits proliferation and inflammatory responses of RMC through regulating AKT/GSK pathway by targeting CXCL16
Junbiao Wu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Sitagliptin ameliorates diabetic nephropathy by blocking TGF-1/Smad signaling pathway
Dongdong Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
Rhein attenuates inflammation through inhibition of NF-.B and NALP3 inflammasome in vivo and in vitro
Hui Ge et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Rhein ameliorates adenomyosis by inhibiting NF-κB and β-Catenin signaling pathway
Tingting Feng et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Primary glomerulonephritides
Juergen Floege et al.
LANCET (2016)
Counting on natural products for drug design
Tiago Rodrigues et al.
NATURE CHEMISTRY (2016)
Rhein prevents endotoxin-induced acute kidney injury by inhibiting NF-κB activities
Chen Yu et al.
SCIENTIFIC REPORTS (2015)
Glomerular Diseases: FSGS
Bhadran Bose et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
The Molecular Mechanism of Rhein in Diabetic Nephropathy
Cong-Cong Zeng et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Protection of rhein on IgA nephropathy mediated by inhibition of fibronectin expression in rats
Peng Sheng-Nan et al.
INDIAN JOURNAL OF PHARMACOLOGY (2013)
Preventive Effects and Mechanisms of Rhein on Renal Interstitial Fibrosis in Obstructive Nephropathy
Dongyuan He et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis
Yeong-Hau H. Lien et al.
NATURE REVIEWS NEPHROLOGY (2011)
Regulation and Function of NF-kappa B Transcription Factors in the Immune System
Sivakumar Vallabhapurapu et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Rhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathway
J-M Zheng et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Shared principles in NF-κB signaling
Matthew S. Hayden et al.
CELL (2008)
New perspectives in treatment of glomerulonephritis
R Coppo et al.
PEDIATRIC NEPHROLOGY (2004)
Efficacy of prednisolone and mizoribine therapy for diffuse IgA nephropathy
Y Kawasaki et al.
AMERICAN JOURNAL OF NEPHROLOGY (2004)
Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade
R Agarwal
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2003)
Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors
G D'Amico
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome
K Yoshioka et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
